Endothelial-Specific Deficiency of ATG5 (Autophagy Protein 5) Attenuates Ischemia-Related Angiogenesis
Authors:
- 1 June 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 39 (6) , 1137-1148
Abstract
Objective—: Pathological angiogenesis, such as exuberant retinal neovascularization during proliferative retinopathies, involves endothelial responses to ischemia/hypoxia and oxidative stress. Autophagy is a clearance system enabling bulk degradation of intracellular components and is implicated in cellular adaptation to stressful conditions. Here, we addressed the role of the ATG5 (autophagy-related protein 5) in endothelial cells in the context of pathological ischemia-related neovascularization in the murine model of retinopathy of prematurity. Approach and Results—: Autophagic vesicles accumulated in neovascular tufts of the retina of retinopathy of prematurity mice. Endothelium-specific Atg5 deletion reduced pathological neovascularization in the retinopathy of prematurity model. In contrast, no alterations in physiological retina vascularization were observed in endothelial-specific ATG5 deficiency, suggesting a specific role of endothelial ATG5 in pathological hypoxia/reoxygenation–related angiogenesis. Consistently, in an aortic ring angiogenesis assay, endothelial ATG5 deficiency resulted in impaired angiogenesis under hypoxia/reoxygenation conditions. As compared to ATG5-sufficient endothelial cells, ATG5-deficient cells displayed impaired mitochondrial respiratory activity, diminished production of mitochondrial reactive oxygen species and decreased phosphorylation of the VEGFR2 (vascular endothelial growth factor receptor 2). Consistently, ATG5-deficient endothelial cells displayed decreased oxidative inactivation of PTPs (phospho-tyrosine phosphatases), likely due to the reduced reactive oxygen species levels resulting from ATG5 deficiency. Conclusions—: Our data suggest that endothelial ATG5 supports mitochondrial function and proangiogenic signaling in endothelial cells in the context of pathological hypoxia/reoxygenation–related neovascularization. Endothelial ATG5, therefore, represents a potential target for the treatment of pathological neovascularization-associated diseases, such as retinopathies.Keywords
This publication has 64 references indexed in Scilit:
- Regulation of mATG9 trafficking by Src- and ULK1-mediated phosphorylation in basal and starvation-induced autophagyCell Research, 2016
- Chronic Vascular Arrest as a Predictor of Bevacizumab Treatment Failure in Retinopathy of PrematurityOphthalmology, 2016
- Molecular pathogenesis of retinal and choroidal vascular diseasesProgress in Retinal and Eye Research, 2015
- ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neuronsHuman Molecular Genetics, 2012
- The Role of Atg Proteins in Autophagosome FormationAnnual Review of Cell and Developmental Biology, 2011
- Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of lifeJournal of Clinical Investigation, 2010
- Regulation Mechanisms and Signaling Pathways of AutophagyAnnual Review of Genetics, 2009
- The Atg12-Atg5 Conjugate Has a Novel E3-like Activity for Protein Lipidation in AutophagyJournal of Biological Chemistry, 2007
- Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4The EMBO Journal, 2007
- Dissection of Autophagosome Formation Using Apg5-Deficient Mouse Embryonic Stem CellsJournal of Cell Biology, 2001